Filter news by date News Tags - Any -News storyPress release Month MonthJanuaryFebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovemberDecember Year Year2024202320222021202020192018201720162015201420132012201120102009200820072006 Apply 4 . 19 . 2012 Press release Q-Med discontinues the Breast Indication for Macrolane 3 . 20 . 2012 Press release Galderma announces Completion of Phase 3 Trials of Investigational Drug targeting Facial Erythema of Rosacea 3 . 12 . 2012 Press release Ipsen and Galderma increase their collaboration for Dysport® in new territories 3 . 6 . 2012 Press release Galderma receives FDA Approval for new convenient Pump Dispenser of Differin Gel, 0.3% for treatment of Acne Vulgaris 1 . 17 . 2012 Press release Galderma Announces Availability of New Metrogel 1% Pump Dispenser for the Treatment of Papulopustular Rosacea 10 . 20 . 2011 Press release Galderma announces positive US pivotal interim 6-month results for EMERVEL Classic Lidocaine compared to JUVEDERM Ultra 10 . 20 . 2011 Press release Galderma announces positive Phase 2B Results for Investigational Compound targeting Redness of Rosacea 3 . 7 . 2011 Press release AstraZeneca and Galderma enter into R&D collaboration to develop new treatments for dermatological diseases 1 . 13 . 2011 Press release Galderma Launches EMERVEL® Range of Hyaluronic Acid Dermal Fillers 11 . 29 . 2010 Press release Galderma announces Results of largest-ever Rosacea Trial 9 . 15 . 2010 Press release Cetaphil® Brand Launches Cetaphil® Restoraderm® -- a new Line of Products to Help 3 . 22 . 2010 Press release Galderma Received FDA Approval of Differin® (adapalene) Lotion, 0.1%, the First Retinoid Available in Lotion Formulation Pagination Previous page Previous Page Next page Next Page